Opia Technologies
Private Company
Funding information not available
Overview
Opia Technologies is a Paris-based, private medical device company specializing in ophthalmology. It is building a portfolio of devices for sampling ocular surface components and for non-invasive ocular drug delivery, leveraging proprietary patents. The company operates a full-service model encompassing R&D, manufacturing, and regulatory services, and benefits from a strategic manufacturing partnership with JB TECNICS. Positioned at the intersection of diagnostics and therapeutic delivery, Opia aims to improve patient care in ocular surface diseases.
Technology Platform
Proprietary platform for minimally invasive sampling of ocular surface components (tear film, conjunctiva) and non-invasive ocular drug delivery via iontophoresis.
Opportunities
Risk Factors
Competitive Landscape
Opia competes in the ocular diagnostics space with companies like TearLab (osmolarity) and others developing biomarker tests. In drug delivery, it faces competition from various sustained-release technologies and other iontophoresis devices. Its integrated service model and veterinary-first strategy provide distinct, but not unassailable, competitive angles.